Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis

被引:7
|
作者
Balmuri, Nayimisha [1 ,2 ]
Soulsby, William Daniel [3 ]
Cooley, Victoria [2 ]
Gerber, Linda [2 ]
Lawson, Erica [3 ]
Goodman, Susan [1 ,2 ]
Onel, Karen [1 ,2 ]
Mehta, Bella [1 ,2 ]
机构
[1] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[2] Weill Cornell Med, New York, NY 10065 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
HEALTH DISPARITIES; RADIOGRAPHIC PROGRESSION; SOCIOECONOMIC MEASURES; DISEASE OUTCOMES; CHILDREN; CARE; ACCESS; DELAY;
D O I
10.1186/s12969-021-00610-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The impact of social determinants of health on children with polyarticular juvenile idiopathic arthritis (pJIA) is poorly understood. Prompt initiation of treatment for pJIA is important to prevent disease morbidity; however, a potential barrier to early treatment of pJIAs is delayed presentation to a pediatric rheumatologist. We examined the impact of community poverty level, a key social determinant of health, on time from patient reported symptom onset to first pediatric rheumatology visit among pJIA patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. Methods: This is a cohort study of pJIA patients in the CARRA registry who lived in the United States from July 2015-February 2020. The primary exposure was community poverty level derived by geocoding patient addresses. The primary outcome was time to first rheumatology appointment. Kaplan-Meier analysis was performed to analyze time to first rheumatologist visit, stratified by community poverty and family income. Log-rank tests were used to identify differences between groups. Adjusted cox proportional-hazards models were used to determine the relationship between community poverty level and time from onset of disease symptoms to date first seen by rheumatologist. Results: A total of 1684 patients with pJIA meeting study inclusion and exclusion criteria were identified. Median age of onset of pJIA was 7 years (IQR 3, 11), 79% were female, 17.6% identified as minority race and/or ethnicity, and 19% were from communities with >= 20% community poverty level. Kaplan-Meier analysis by community poverty level (< 20% vs >= 20%) yielded no significant differences with time to initial presentation to a pediatric rheumatologist (p = 0.6). The Cox proportional hazards model showed that patients with >= 20% community poverty level were 19% less likely (adjusted HR 0.81, 95% CI 0.67-0.99, p = 0.038) to be seen by a rheumatologist compared to patients with < 20% community poverty level, at the same time point, after adjusting for sex, race/ethnicity, insurance, education level, morning stiffness, RF status, and baseline CHAQ. Conclusion: In this study of pJIA patients in the CARRA registry, increased community poverty level is associated with longer time to presentation to a pediatric rheumatologist after symptom onset.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis
    Horneff, Gerd
    Klein, Ariane
    Ganser, Gerd
    Sailer-Hoeck, Michaela
    Guenther, Annette
    Foeldvari, Ivan
    Weller-Heinemann, Frank
    PEDIATRIC RHEUMATOLOGY, 2017, 15
  • [42] Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapolation of Data from Studies in Adults and Adjacent Pediatric Populations
    Jocelyn H. Leu
    Natalie J. Shiff
    Michael Clark
    Karen Bensley
    Kathleen G. Lomax
    Katherine Berezny
    Robert M. Nelson
    Honghui Zhou
    Zhenhua Xu
    Pediatric Drugs, 2022, 24 : 699 - 714
  • [43] Implementing Treat to Target Approach in the Care of Juvenile Idiopathic Arthritis Across a Network of Pediatric Rheumatology Centers
    Harris, Julia
    Morgan, Esi
    Taylor, Janalee
    Qiu, Tingting
    Griffin, Nancy
    Paul, Anne
    Bingham, C. April
    Bullock, Danielle
    Ferraro, Kerry
    Gilbert, Mileka
    Goh, Y. Ingrid
    Halyabar, Olha
    Jones, Karla
    Kohlheim, Melanie
    Lovell, Daniel J.
    Smitherman, Emily
    Vago, Anjie
    Weiss, Jennifer
    Yildirim-Toruner, Cagri
    Young, Angela
    Batthish, Michelle
    Gottlieb, Beth
    Hazen, Melissa
    Laxer, Ronald
    Lee, Tzielan
    Mannion, Melissa
    Olson, Judyann
    Shishov, Michael
    Siddique, Salma
    Spencer, Charles
    Toth, Mary
    Vora, Sheetal
    Burnham, Jon
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 : 1 - 3
  • [44] New Juvenile Idiopathic Arthritis Quality Measure Set for the Pediatric Rheumatology Care and Outcomes Improvement Network
    Harris, Julia
    Morgan, Esi
    Vora, Sheetal
    Gilbert, Mileka
    Yildirim-Toruner, Cagri
    Griffin, Nancy
    Ferraro, Kerry
    Loos, Stephanie
    Qiu, Tingting
    Paul, Anne
    Burnham, Jon
    Meyer, Erik
    Batthish, Michelle
    Gottlieb, Beth
    Bullock, Danielle
    Hazen, Melissa
    Laxer, Ronald
    Lee, Tzielan
    Mannion, Melissa
    Olson, Judyann
    Shishov, Michael
    Vehe, Richard
    Weiss, Jennifer
    Bingham, C. April
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 : 299 - 301
  • [45] Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER
    Sezgin Sahin
    Ceyhun Acari
    Hafize Emine Sonmez
    Fatma Zehra Kilic
    Erdal Sag
    Hatice Adiguzel Dundar
    Amra Adrovic
    Selcan Demir
    Kenan Barut
    Yelda Bilginer
    Betul Sozeri
    Erbil Unsal
    Seza Ozen
    Ozgur Kasapcopur
    Pediatric Rheumatology, 19
  • [46] Measuring Quality of Care in Juvenile Idiopathic Arthritis: The Pediatric Rheumatology Care and Outcomes Improvement Network.
    DeWitt, Esi Morgan
    Beukelman, Timothy
    Gottlieb, Beth S.
    Griffin, Nancy
    Kimura, Yukiko
    Barnes, Itara
    Passo, Murray H.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S803 - S804
  • [47] Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Outcome Improvement for Children with Juvenile Idiopathic Arthritis
    Bingham, Catherine
    Harris, Julia
    Vora, Sheetal
    Gilbert, Mileka
    Yildirim-Toruner, Cagri
    Ferraro, Kerry
    Qiu, Tingting
    Burnham, Jon
    Batthish, Michelle
    Gottlieb, Beth
    Lovell, Daniel
    Laxer, Ronald
    Lee, Tzielan
    Bullock, Danielle
    Spencer, Charles H.
    Weiss, Jennifer
    Hazen, Melissa
    Oberle, Edward
    Mannion, Melissa
    Pan, Nancy
    Shishov, Michael
    Fair, Danielle
    Toth, Mary
    Wiegand, Kendra
    Morgan, Esi
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2555 - 2558
  • [48] The pediatric rheumatology quality of life scale: validation of the English version in a US cohort of juvenile idiopathic arthritis
    Weiss, Pamela F.
    Klink, Andrew J.
    Faerber, Jennifer
    Feudtner, Chris
    PEDIATRIC RHEUMATOLOGY, 2013, 11
  • [49] Transitions from pediatric to adult rheumatology care for juvenile idiopathic arthritis: a patient led qualitative study
    Gillian R. Currie
    M. Harris
    L. McClinton
    N. Trehan
    A. Van Dusen
    M. Shariff
    T. Kuzmyn
    D. A. Marshall
    BMC Rheumatology, 6
  • [50] Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER
    Sahin, Sezgin
    Acari, Ceyhun
    Sonmez, Hafize Emine
    Kilic, Fatma Zehra
    Sag, Erdal
    Dundar, Hatice Adiguzel
    Adrovic, Amra
    Demir, Selcan
    Barut, Kenan
    Bilginer, Yelda
    Sozeri, Betul
    Unsal, Erbil
    Ozen, Seza
    Kasapcopur, Ozgur
    PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)